Portfolio
InSightec was established in January 1999. The company developed a breakthrough technology that in essence allows treating human beings without cutting the body. They developed technological systems that allow the destruction of targets deep inside the body completely non-invasive. The unique part of InSightec is that all these procedures are being done under real time monitoring and control of treatment outcome. So the user is capable of changing treatment parameters on-the-fly, not in retrospect and achieves the desired outcome. As the dominant MRgFUS solution, the company has cooperated with the main global MRI vendors such as GE\Siemens\UI.
Cnoga Medical, founded in 2004, is an innovative developer of easy-to-use, non-invasive medical devices for personal use. With a vision of empowering people, Cnoga Medical is helping to realize a future where people conduct simple, needle-free blood tests in the comfort of their own homes. The company has developed the world’s first non-invasive glucose meter.
Highcon, founded in 2009, is dedicated to streamlining the converting process to meet the numerous challenges facing folding carton manufacturers and their brand owner customers. The company develops, manufactures and markets a revolutionary digital converting solution for the Direct-to-Pack Folding Carton sector. Highcon’s ‘DART’ (Digital Adhesive Rule Technology) has been incorporated into the world’s first production digital cutting and creasing machine, the Highcon Euclid, which transforms cutting and creasing from an analogue to a digital workflow, dramatically streamlining the finishing process.
Kaymera, founded in 2013, was founded by veterans in the cyber security industry with in depth knowledge and expertise in mobile security and cyber-attack methods to assess and breach stringent security measures. Kaymera delivers the most sophisticated Mobile defense system to protect organizations, governments and individuals
from all mobile security threats, while supporting freedom of use on popular smartphone models.
VGS (Vascular Graft Solutions), founded in 2009, develops innovative solutions to improve the outcome of bypass surgery and patients’ quality of life.
VEST, the company’s leading product, is a hybrid biological conduit that combines the benefits of both arterial and venous conduits. This next generation conduit aims to drive a significant change in CABG paradigm and improve its long-term clinical outcomes extremely.
Idomoo, founded in 2008, brings together the power of video and the effectiveness of personalization to create a new communications platform. In another word, Idomoo delivers video-based digital CRM solutions for enterprises to improve their personal communication with their customers. The Idomoo PVaaS (Personalized Video as a Service)
platform integrates customer data from CRM systems with a master video to generate massive numbers of individually relevant, high-quality, professional video clips.
XJet Ltd. was founded in 2005 by Hanan Gothait, an innovator and veteran of the inkjet printing industry. XJet brings to market the first ground-breaking inkjet-based 3D printing system for metal parts.
XJet pioneered NanoParticle Jetting™ technology to transform the metal additive manufacturing industry. Bringing a new level of quality to metal manufacturing, XJet’s NanoParticle Jetting™ technology uses solid metal nanoparticles suspended in liquid “ink” in sealed cartridges. An ultra-fine layer of liquid droplets containing stochastic metal and support nanoparticles is deposited onto the system build-tray. This produces metal parts with the same ease and versatility of inkjet printing without compromising throughput.
Sight Diagnostics was founded in 2011, specializes in utilizing advanced computer vision and machine learning technology in the realm of blood diagnostics.
Sight’s initial product, the Parasight platform, is the world’s first automated microscopy device for Malaria diagnosis. Malaria is still one of the world’s deadliest diseases, largely due to ineffective and costly diagnosis. This revolutionary platform provides better accuracy and ease of use. This product completed development and commercialization and is being sold and used in medical centers in India, Africa and Europe, becoming the first new commercial diagnostic in the malaria field since the inception of PCR.
VectoriousTM technology helps physicians to help patients help themselves. Via a simple, minimally-invasive implanted device, easy-to-access data and user-friendly external home-unit;
the VectoriousTM system increases CHF patient quality of life and reduces readmission rates.
Daily 'push button' readings of patient hemodynamic pressure provide early, accurate physiological indication of cardiac decompensation. Patients enjoy ongoing, personalized care, physicians save lives and cut healthcare costs.
Body Vision Medical was founded in 2014 by Dorian Averbuch. Averbuch pioneered, developed and commercialized a novel electromagnetic navigation bronchoscopy approach at superDimension, where he learned about the broad field of interventional pulmonology and the specific challenges of early lung cancer detection.
From the start, Body Vision Medical’s vision has been to create a bridge into the new world, a world without lung cancer. To reach this vision, the company would forge a path to address the contemporary unmet clinical need of early lung cancer diagnostics and prepare for future minimally invasive treatments.